NON-RENAL CELL CARCINOMA OF KIDNEY

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting NON-RENAL CELL CARCINOMA OF KIDNEY:

# Drug Count
0 GEMCITABINE 15
1 GEMCITABINE HYDROCHLORIDE 15
2 CISPLATIN 10
3 DOXORUBICIN 10
4 CARBOPLATIN 5
5 PACLITAXEL 5
6 PACLITAXEL (AIBUMIN-BOUND) 5
7 METHOTREXATE 4
8 METHOTREXATE SODIUM 4
9 BEVACIZUMAB 3
See all common drugs associated with NON-RENAL CELL CARCINOMA OF KIDNEY

NON-RENAL CELL CARCINOMA OF KIDNEY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN HYDROCHLORIDE 1 0.0004
1 GEMCITABINE HYDROCHLORIDE 15 0.0003
2 PEGFILGRASTIM 2 0.0002
3 TOPOTECAN 1 0.0002
4 ERLOTINIB HYDROCHLORIDE 2 0.0002
5 ZOLMITRIPTAN 1 0.0001
6 CISPLATIN 10 0.0001
7 EVEROLIMUS TABLETS 2 0.0001
8 DOXORUBICIN 10 0.0001
9 IFOSFAMIDE FOR INJECTION 2 0.0001
See all drugs enriched for association with NON-RENAL CELL CARCINOMA OF KIDNEY